Shandong Lukang Pharmaceutical Co.,Ltd.’s Net Profit Rose 59.2% in 2022

Shandong Lukang Pharmaceutical Co.,Ltd. (山东鲁抗医药股份有限公司) (600789.SH) reported a net profit of 143.1 million yuan in 2022, up 59.2% year-on-year.

Meanwhile, the company posted 5.6 billion yuan in revenue, up 14.2% year-on-year.

At the end of the reporting period, it had 8.7 billion yuan in total assets and 5.2 billion yuan in total liabilities, with a liability-to-asset ratio of 59.8%.